HCFP/Capital Partners 18B-2 LLC 13D/13G Filings for Scopus BioPharma Inc. (SCPS)

HCFP/Capital Partners 18B-2 LLC 13D and 13G filings for Scopus BioPharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2021-11-26
5:00 pm
Sale		2021-11-2313DScopus BioPharma Inc.
SCPS		HCFP/Capital Partners 18B-2 LLC237,092
1.100%		-2,994,150decrease
(-92.66%)		Filing
2021-08-12
07:13 am
Purchase		2021-08-0213DScopus BioPharma Inc.
SCPS		HCFP/Capital Partners 18B-2 LLC3,231,242
15.300%		3,231,242increase
(New Position)		Filing